Regulatory Environment Unfavourable For Pharma Companies: Surjit Pal
Surjit Pal, pharma analyst at Prabhudas Lilladher, says given price competition, competitive horizon in US and regulatory interferences indicate the overall scenario is not supportive for generic Prabhudas Lilladher players.
![Gadgets 360 With Technical Guruji: Ask TG [April 5, 2025]](https://c.ndtvimg.com/2025-04/8pgjm1vc_ask-tg_160x120_05_April_25.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: Ask TG [April 5, 2025]")
![Gadgets 360 With Technical Guruji: News of the Week [April 5, 2025]](https://c.ndtvimg.com/2025-04/pt0ck3cc_news-of-the-week_160x120_05_April_25.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: News of the Week [April 5, 2025]")
